Nanospectra Biosciences, Inc.

Nanospectra Biosciences, Inc. (Nanospectra) is a privately held, emerging life science company, engaged in commercializing particle based therapies for the selective and precise thermal destruction of solid tumors. Nanospectra is focused on the development of AuroLase therapy based on AuroShell particles for the precise, particle-based thermal ablation of solid tumors. In addition, the company also offers research-use-only nanoparticles with specific optical characteristics. Nanospectra is headquartered at Houston in Texas, the US.

Street: 
8285 El Rio Street, Suite 150
City: 
Houston
Postcode: 
77054
Federal State : 
United States
WebSite: 
www.nanospectra.com
Fax: 
--713 440 9349

Company Index Score

Current Index Score Historical Index Score
  • Nanospectra Biosciences, Inc. currently scores 50 % in the index.
  • Nanospectra Biosciences, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Nanospectra Biosciences, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets